logo
logo

Podimetrics Secures $45 Million Series C To Help At-Risk Providers And Health Plans Prevent Diabetic Amputations In High-Risk Patients

Mar 24, 2022•over 3 years ago

Amount Raised

$45 Million

Round Type

series c

Somerville

Description

Podimetrics, creator of the FDA-cleared SmartMatTM and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes, today announced a $45 million Series C round led by D1 Capital Partners, along with two new investors, the Medtech Convergence Fund and an undisclosed strategic investor. Existing investors, Polaris Partners and Scientific Health Development, also participated in the financing. Prior to their Series C, Podimetrics had raised $28.3 million in funding to fuel development and distribution of their SmartMat.

Company Information

Company

Podimetrics

Location

Somerville, Pennsylvania, United States

About

Podimetrics is the creator of the FDA-cleared SmartMatTM and integrated clinical care services that can help save the limbs and lives of complex diabetic patients. Through partnerships with regional and national health plans and at-risk providers, such as the Veterans Health Administration, Podimetrics has helped prevent amputations associated with complex diabetes. By combining cutting-edge technology with best-in-class clinical care services, Podimetrics earns high engagement rates from patients and allows clinicians to save limbs, lives, and money — all while keeping vulnerable populations healthy in their own homes. For more information, visit podimetrics.com or follow us on LinkedIn and Twitter.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech